MétaCan
Menu
← Back to cohort

Beliefs and Practices of Canadian and U.S. Physicians Regarding the Use of Probiotics for Gastrointestinal Illnesses

2018· article· en· W2922437294 on OpenAlexaffabout
Premysl Bercik, Brian Craig, Eytan Wine, Brian Yan, William D. Chey

Bibliographic record

VenueThe American Journal of Gastroenterology · 2018
Typearticle
Languageen
FieldMedicine
TopicClostridium difficile and Clostridium perfringens research
Canadian institutionsWestern UniversityUniversity of AlbertaSaint John Regional HospitalMcMaster University
Fundersnot available
KeywordsMedicineIrritable bowel syndromePouchitisFamily medicineProbioticInternal medicineDiarrheaAlternative medicineUlcerative colitisDiseasePathology

Abstract

fetched live from OpenAlex

Introduction: Despite the popularity of probiotics with patients, little is known about their utilization and knowledge among Gastroenterologists (GIs) and Family Physicians (FPs). The Canadian Association of Gastroenterology (CAG) developed a needs assessment (NA) to determine utilization and knowledge patterns. Methods: A NA was developed based on the expert opinions and emailed to the members of the CAG, the American College of Gastroenterology (ACG), and other networks of FPs in the US and CAN. Results: A total of 276 physicians, ˜50% from US and CAN, responded to the NA. Respondents were mainly adult GIs (68%), from all “stages of career”, mostly male and from community/private setting, residing in large cities. Most physicians recommend probiotics to their patients (92%-CAN, 85%-US). The top reason for not recommending probiotics was lack of clinical evidence. Among physicians recommending probiotics, a given probiotic was selected based on clinical evidence of efficacy (70%-CAN; 56%-US), or because of a specific strain (44%-CAN; 48%-US). Top information sources were scientific/clinical literatureand clinical guidelines. Choice of a probiotic was determined mostly by clinical data (89%-CAN; 90%-US), followed by cost of probiotics, their stability, manufacturer credibility and manufacturing quality. Probiotics were most commonly recommended for Irritable Bowel Syndrome (IBS; 77%-CAN; 58%-US), followed by diarrhea (53%-CAN; 46%-US), pouchitis (33%-CAN; 38%-US), and constipation/ulcerative colitis (UC)/dyspepsia (all 5-16%). The actual use of probiotics in patients with specific diseases differed slightly between CAN and US (Table 1). Pills/capsules were the most recommended form of probiotic, mostly containing mixture of bacterial species, followed by Bifidobacterium and Lactobacillus.Rationale for recommending probiotics was based equally on personal belief in benefit and scientific evidence; the key exceptions being pouchitis followed by UC, where scientific evidence prevailed. Doctors felt that marketing had little impact (0-6% of all physicians). While most physicians felt fairly or very well informed (53%-CAN; 67%-US), a significant proportion of respondents (30%-CAN, 22%-US) were only somewhat informed. Conclusion: Probiotics are used commonly among GIs and FPs in CAN and US, mainly to treat functional GI disorders. However, knowledge of clinical data and scientific evidence for use of probiotics is discrepant among physicians in both countries.432 Figure 1. n=number of physicians who recommend probiotics for that indication; All results expressed in %.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.009
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.165
Threshold uncertainty score0.332

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.009
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.002
Science and technology studies0.0020.001
Scholarly communication0.0010.000
Open science0.0000.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.057
GPT teacher head0.322
Teacher spread0.265 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2018
Admission routes2
Has abstractyes

Explore more

Same venueThe American Journal of Gastroenterology→Same topicClostridium difficile and Clostridium perfringens research→French-language works237,207→